Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Neurotropism, micRoglial ActivatioN and Cytokine dySregulaTiOn in COVID-19 Patients With Delirium

NCT04785157 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04785157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04785157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Neurotropism, micRoglial ActivatioN and Cytokine dySregulaTiOn in COVID-19 Patients With Delirium
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
June 30, 2022
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, delirium, post-traumatic stress disorder